Tempus AI (TEM) Net Margin (2023 - 2026)
Tempus AI's (TEM) quarterly Net Margin came in at 2.22% in Q2 2026, up 1584.0% year-over-year from 0.13% in Q2 2025, and up 106.3% quarter-over-quarter from 35.29% in Q1 2026.
Powered by 
Analysis
Tempus AI (TEM) Net Margin (2023 - 2026) Analysis & Trends
Tempus AI (TEM) has reported Net Margin for 4 consecutive years, with 2.22% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin rose 1584.0% year-over-year to 2.22% in Q2 2026; TTM through Jun 2026 was 17.35%, a 363.0% increase from a year earlier, with the FY2025 full-year figure at 19.27%, up 8837.0% from the prior year.
- Net Margin was 2.22% for Q2 2026 at Tempus AI, up from 35.29% in the prior quarter.
- Over five years, Net Margin peaked at 2.22% in Q2 2026 and troughed at 340.08% in Q2 2024.
- A 4-year average of 54.53% and a median of 35.29% in 2026 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 28912 bps in 2024 and jumped 32646 bps in 2025, its largest moves.
- Over 4 years, Net Margin stood at 45.62% in 2023, then surged by 86 bps to 6.48% in 2024, then sank by 127 bps to 14.75% in 2025, then jumped by 115 bps to 2.22% in 2026.
- The last three Net Margin figures came in at 2.22% (Q2 2026), 35.29% (Q1 2026), and 14.75% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | -8.89% |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 8.02% |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | 10.65% |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | -35.87% |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | 2.22% |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | -0.24% |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 16.69% |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 7.36% |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | -0.17% |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | -22.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.22% |
| Mar 31, 2026 | -35.29% |
| Dec 31, 2025 | -14.75% |
| Sep 30, 2025 | -23.93% |
| Jun 30, 2025 | -13.62% |
| Mar 31, 2025 | -26.60% |
| Dec 31, 2024 | -6.48% |
| Sep 30, 2024 | -41.92% |
| Jun 30, 2024 | -340.08% |
| Mar 31, 2024 | -63.82% |
| Dec 31, 2023 | -45.62% |
| Sep 30, 2023 | -48.02% |
| Jun 30, 2023 | -50.96% |